Vascular responsiveness to phorbol esters in coarctation-hypertensive rats

Mila B. Turla, Samuel M. Park, R Clinton Webb

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Recent observations suggest that a phospholipid-sensitive, calcium-dependent protein kinase affects the contractile responses of vascular smooth muscle. Protein kinase C activators such as the tumor-promoting phorbol esters have been used as tools to study protein kinase C function in various intact cells. The present study characterizes vascular reactivity to protein kinase C activation in rats made hypertensive by coarctation of the abdominal aorta. Thoracic aortic strips from hypertensive rats developed greater force than arteries from normotensive rats in response to the phorbol ester, 12-Otetradecanoylphorbol-13-acetate (TPA). Thoracic aortae from hypertensive rats were more responsive (lower threshold dose) to the phorbol ester than those from normotensive rats. Additionally, arteries from hypertensive rats were more responsive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Removal of the endothelium did not eliminate the difference in responsiveness to TPA in thoracic aortae from normotensive and hypertensive rats. The threshold dose of TPA in abdominal aortae from hypertensive rats was not different from that in normotensive rats. However, the maximal response to 10−6mol/l TPA after 60min in abdominal aortae from hypertensive rats was significantly less than that in aortae from normotensive rats. Thus, contractile responses to TPA appear to be influenced by arterial pressure per se. The inhibitory effects of the calcium antagonist, verapamil, in thoracic aortae from hypertensive rats were greater than in those from normotensive rats. Verapamil inhibited TPA-induced contractions in abdominal aortae from hypertensive rats to the same extent as in those from normotensive rats. These results suggest that increased activity of the protein kinase C branch of the phosphoinositide second messenger system may underlie increased vascular reactivity to various hormones and neurotransmitters in this experimental model of hypertension.

Original languageEnglish (US)
Pages (from-to)191-196
Number of pages6
JournalJournal of hypertension
Volume8
Issue number2
DOIs
StatePublished - Jan 1 1990

Fingerprint

Phorbol Esters
Blood Vessels
Protein Kinase C
Acetates
Abdominal Aorta
Thoracic Aorta
Verapamil
Arteries
Aortic Coarctation
Second Messenger Systems
Phosphatidylinositols
Vascular Smooth Muscle
Endothelium
Neurotransmitter Agents
Aorta
Arterial Pressure
Esters

Keywords

  • Aorta
  • Blood pressure
  • Protein kinase c
  • Vascular reactivity

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Vascular responsiveness to phorbol esters in coarctation-hypertensive rats. / Turla, Mila B.; Park, Samuel M.; Webb, R Clinton.

In: Journal of hypertension, Vol. 8, No. 2, 01.01.1990, p. 191-196.

Research output: Contribution to journalArticle

Turla, Mila B. ; Park, Samuel M. ; Webb, R Clinton. / Vascular responsiveness to phorbol esters in coarctation-hypertensive rats. In: Journal of hypertension. 1990 ; Vol. 8, No. 2. pp. 191-196.
@article{e3182e059f784cf2b9ec5dd3c86a110b,
title = "Vascular responsiveness to phorbol esters in coarctation-hypertensive rats",
abstract = "Recent observations suggest that a phospholipid-sensitive, calcium-dependent protein kinase affects the contractile responses of vascular smooth muscle. Protein kinase C activators such as the tumor-promoting phorbol esters have been used as tools to study protein kinase C function in various intact cells. The present study characterizes vascular reactivity to protein kinase C activation in rats made hypertensive by coarctation of the abdominal aorta. Thoracic aortic strips from hypertensive rats developed greater force than arteries from normotensive rats in response to the phorbol ester, 12-Otetradecanoylphorbol-13-acetate (TPA). Thoracic aortae from hypertensive rats were more responsive (lower threshold dose) to the phorbol ester than those from normotensive rats. Additionally, arteries from hypertensive rats were more responsive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Removal of the endothelium did not eliminate the difference in responsiveness to TPA in thoracic aortae from normotensive and hypertensive rats. The threshold dose of TPA in abdominal aortae from hypertensive rats was not different from that in normotensive rats. However, the maximal response to 10−6mol/l TPA after 60min in abdominal aortae from hypertensive rats was significantly less than that in aortae from normotensive rats. Thus, contractile responses to TPA appear to be influenced by arterial pressure per se. The inhibitory effects of the calcium antagonist, verapamil, in thoracic aortae from hypertensive rats were greater than in those from normotensive rats. Verapamil inhibited TPA-induced contractions in abdominal aortae from hypertensive rats to the same extent as in those from normotensive rats. These results suggest that increased activity of the protein kinase C branch of the phosphoinositide second messenger system may underlie increased vascular reactivity to various hormones and neurotransmitters in this experimental model of hypertension.",
keywords = "Aorta, Blood pressure, Protein kinase c, Vascular reactivity",
author = "Turla, {Mila B.} and Park, {Samuel M.} and Webb, {R Clinton}",
year = "1990",
month = "1",
day = "1",
doi = "10.1097/00004872-199002000-00015",
language = "English (US)",
volume = "8",
pages = "191--196",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Vascular responsiveness to phorbol esters in coarctation-hypertensive rats

AU - Turla, Mila B.

AU - Park, Samuel M.

AU - Webb, R Clinton

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Recent observations suggest that a phospholipid-sensitive, calcium-dependent protein kinase affects the contractile responses of vascular smooth muscle. Protein kinase C activators such as the tumor-promoting phorbol esters have been used as tools to study protein kinase C function in various intact cells. The present study characterizes vascular reactivity to protein kinase C activation in rats made hypertensive by coarctation of the abdominal aorta. Thoracic aortic strips from hypertensive rats developed greater force than arteries from normotensive rats in response to the phorbol ester, 12-Otetradecanoylphorbol-13-acetate (TPA). Thoracic aortae from hypertensive rats were more responsive (lower threshold dose) to the phorbol ester than those from normotensive rats. Additionally, arteries from hypertensive rats were more responsive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Removal of the endothelium did not eliminate the difference in responsiveness to TPA in thoracic aortae from normotensive and hypertensive rats. The threshold dose of TPA in abdominal aortae from hypertensive rats was not different from that in normotensive rats. However, the maximal response to 10−6mol/l TPA after 60min in abdominal aortae from hypertensive rats was significantly less than that in aortae from normotensive rats. Thus, contractile responses to TPA appear to be influenced by arterial pressure per se. The inhibitory effects of the calcium antagonist, verapamil, in thoracic aortae from hypertensive rats were greater than in those from normotensive rats. Verapamil inhibited TPA-induced contractions in abdominal aortae from hypertensive rats to the same extent as in those from normotensive rats. These results suggest that increased activity of the protein kinase C branch of the phosphoinositide second messenger system may underlie increased vascular reactivity to various hormones and neurotransmitters in this experimental model of hypertension.

AB - Recent observations suggest that a phospholipid-sensitive, calcium-dependent protein kinase affects the contractile responses of vascular smooth muscle. Protein kinase C activators such as the tumor-promoting phorbol esters have been used as tools to study protein kinase C function in various intact cells. The present study characterizes vascular reactivity to protein kinase C activation in rats made hypertensive by coarctation of the abdominal aorta. Thoracic aortic strips from hypertensive rats developed greater force than arteries from normotensive rats in response to the phorbol ester, 12-Otetradecanoylphorbol-13-acetate (TPA). Thoracic aortae from hypertensive rats were more responsive (lower threshold dose) to the phorbol ester than those from normotensive rats. Additionally, arteries from hypertensive rats were more responsive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Removal of the endothelium did not eliminate the difference in responsiveness to TPA in thoracic aortae from normotensive and hypertensive rats. The threshold dose of TPA in abdominal aortae from hypertensive rats was not different from that in normotensive rats. However, the maximal response to 10−6mol/l TPA after 60min in abdominal aortae from hypertensive rats was significantly less than that in aortae from normotensive rats. Thus, contractile responses to TPA appear to be influenced by arterial pressure per se. The inhibitory effects of the calcium antagonist, verapamil, in thoracic aortae from hypertensive rats were greater than in those from normotensive rats. Verapamil inhibited TPA-induced contractions in abdominal aortae from hypertensive rats to the same extent as in those from normotensive rats. These results suggest that increased activity of the protein kinase C branch of the phosphoinositide second messenger system may underlie increased vascular reactivity to various hormones and neurotransmitters in this experimental model of hypertension.

KW - Aorta

KW - Blood pressure

KW - Protein kinase c

KW - Vascular reactivity

UR - http://www.scopus.com/inward/record.url?scp=0025279847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025279847&partnerID=8YFLogxK

U2 - 10.1097/00004872-199002000-00015

DO - 10.1097/00004872-199002000-00015

M3 - Article

VL - 8

SP - 191

EP - 196

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 2

ER -